✦ LIBER ✦

Safety and efficacy of second-line treatment with folinic acid, 5-fluorouracil and irinotecan (FOLFIRI) in combination of panitumumab and bevacizumab for patients with metastatic colorectal cancer

✍ Scribed by Xie, Song; Han, Guoping; Fan, Zhikun; He, Lifeng; Xu, Wenbing; Qin, Zhen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combining bevacizumab and panitumumab wi

✍ Liang, Hong-Liang; Hu, Ai-Ping; Li, Sen-Lin; Liu, Ji-Yong 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 195 KB

6083 Final results from PRECEPT: efficac

✍ Cohn, A.; Smith, D.A.; Neubauer, M.A.; Richards, D.; Watkins, D.L.; Zhang, K.; Y 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Bevacizumab plus irinotecan, 5-fluoroura

✍ Deng, Ting; Zhang, Le; Liu, Xiao-jian; Xu, Jian-ming; Bai, Yu-xian; Wang, Yan; H 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 199 KB

664 PUBLICATION Cetuximab in combination

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 137 KB

A retrospective observational study on t

✍ López, R; Salgado, M; Reboredo, M; Grande, C; Méndez, J C; Jorge, M; Romero, C; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 320 KB

Bevacizumab in combination with biweekly

✍ García-Alfonso, P; Muñoz-Martin, A J; Alvarez-Suarez, S; Jerez-Gilarranz, Y; Rie 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 243 KB